Mayo Clinic study shows AI can help clinicians identify brain tumor risks
recent articles
Lumea, dedicated to advancing tissue standardization and digital pathology, solidified its position in the United States in the latest KLAS Research LEHI, UTAH, USA, February 8, 2024 /EINPresswire.com/ — Lumea, a trailblazing digital...
Nijmegen, the Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced a distribution collaboration with Paige, a global leader in AI-based...
Corista: DP3’s momentum as a world-class integrated pathology solution grows Concord, MA (Feb. 7, 2024) – Corista, a leader in digital pathology solutions, is excited to announce that it has received a Class II Medical Device License...
From Aiosyn blog: Diana Rosentul, a Regulatory Affairs Specialist at Aiosyn, intricately manages the regulatory landscape associated with the integration of AI-based solutions within clinical and research institutions. Drawing upon her...
Qritive Secures Multi-Year Contracts to Drive AI Adoption in Pathology Across India MUMBAI, India & SINGAPORE--(BUSINESS WIRE)--QritiveTM, a leading provider of AI solutions for pathology labs worldwide, announces partnership with...
ArteraAI: The funding will support the international expansion and commercial growth of the company and its first-of-its-kind test SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based...
































